SCGB3A1 and breast cancer: To investigate the potential stem cell phenotype associated with activin B or SCGB3A1 signatures in clinical samples, we stratified gene expression datasets from breast cancer patients (METABRIC or lung metastasis samples) based on expression of activin B or SCGB3A1 signatures (Fig. 4f and Supplementary Tables 7 and 8).